MASARAT Mobility Park Announced Agreements with TASARU Supplier Hub to Advance Automotive Manufacturing Localization
10.2.2026 09:11:00 EET | Business Wire | Press release
MASARAT Mobility Park, Saudi Arabia’s premier destination for automotive and mobility industries, has entered into development lease agreements with TASARU Supplier Hub, a strategic initiative by TASARU Mobility Investments (a PIF company) This partnership underpins long-term industrial localization, reinforces the national automotive supply chain, and significantly enhances the Park’s value proposition for Original Equipment Manufacturers (OEMs) and suppliers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210736469/en/
From left to right: Muhammed Alshiha, Chairman of MASARAT Mobility Park; Tienie Ferreira, CEO of MASARAT Mobility Park; Michael Müller, CEO of TASARU Mobility Investments; and Omar Al-Madhi, Chairman of TASARU Mobility Investments, during the signing ceremony at the PIF Private Sector Forum 2026 in Riyadh. (Photo: AETOSWire)
As announced at the 4th edition of PIF Private Sector Forum 2026, these agreements enable TASARU Supplier Hub to develop manufacturing facilities at MASARAT Mobility Park to host global Tier-1 automotive suppliers serving OEMs, such as Ceer, the first Saudi electric vehicle brand, and Lucid Motors. Located within King Salman Automotive Cluster in the Special Economic Zone (SEZ) at King Abdullah Economic City (KAEC), this initiative represents a strategic step toward accelerating the Kingdom’s ambition to build a world-class automotive and mobility ecosystem in line with Saudi Vision 2030.
Through this collaboration, MASARAT Mobility Park will provide an integrated, investment-ready industrial environment designed to support advanced manufacturing operations, streamline supplier setup, and enable efficient logistics and operational connectivity, strengthening the Park’s role as a key enabler of automotive supply chain localization. Supported by proximity to OEMs within the King Salman Automotive Cluster, the Park strengthens its role as a key enabler of automotive supply chain localization.
Tienie Ferreira, CEO of MASARAT Mobility Park, commented:
“These agreements represent a strategic step in advancing MASARAT Mobility Park as a purpose-built platform for automotive manufacturing. Partnering with TASARU Supplier Hub accelerates the localization of critical suppliers, strengthens supply-chain readiness and supports the growth of a competitive automotive ecosystem within KAEC. This development aligns with the objectives of the Saudi Vision 2030 to build a resilient, globally competitive automotive and mobility sector.”
Abdulaziz Almutairi, CEO of TASARU Supplier Hub, added: “TASARU Supplier Hub is designed to translate industrial ambition into execution. By onboarding Tier-1 global suppliers within an investment-ready platform, we advance local content, enable faster time-to-production, and deepen private-sector participation, directly supporting Vision 2030’s objectives for a competitive, export-capable automotive supply chain.”
This milestone reinforces MASARAT Mobility Park’s role as a strategic industrial platform within the King Salman Automotive Cluster, attracting international automotive players and integrating manufacturers, suppliers, and service providers into a single ecosystem. The agreement supports the localization of manufacturing capabilities, advances economic diversification, creates high-value jobs, and strengthens Saudi Arabia’s position as a regional and global hub for the automotive and mobility industries.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20260210736469/en/
Contacts
Dina Redwan
Info@masarat-kaec.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 11:00:00 EET | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 11:00:00 EET | Press release
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro
IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 11:00:00 EET | Press release
The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying the foundations for the evolution of AI-supported oncological diagnostics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210610418/en/ On this
Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 11:00:00 EET | Press release
Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 10:15:00 EET | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living with NT1. NT1 is a chronic, rare neurological disease caused by a loss of orexin and characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone). This results in a spectrum of physical, cognitive and psychosocial effects that can have a debilitating impact on many aspects of a person’s life, including work, education and social interactio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom